Cargando…
Sex, Gender, and the Regulation of Prescription Drugs: Omissions and Opportunities
The regulation of prescription drugs is an important health, safety, and equity issue. However, regulatory processes do not always consider evidence on sex, gender, and factors such as age and race, omissions that advocates have highlighted for several decades. Assessing the impact of sex-related fa...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9962082/ https://www.ncbi.nlm.nih.gov/pubmed/36833654 http://dx.doi.org/10.3390/ijerph20042962 |